Wockhardt has informed that Credit Analysis & Research (CARE Rating) has re-affirmed the Company’s Rating for total Working Capital limit as AA and A1+ for Long - Term Bank Facilities (Fund Based) and Short Term Bank Facilities (Non Fund Based) respectively. Further, India Ratings and Research Private has re-affirmed the short-term Bank facilities rating at A1+ and assigned the Company’s long-term loan facilities rating to AA- from AA. CARE Rating has also assigned AA rating for the proposed issue of NCDs of Rs 250 crore of the Company.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1865.95 |
| Dr. Reddys Labs. | 1339.35 |
| Cipla | 1456.95 |
| Zydus Lifesciences | 1108.85 |
| Lupin | 2396.50 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: